Right, time to point out what I think is happening (IMO)...

Right, time to point out what I think is happening (IMO) (Guessing) seems obvious, what you guys think

IMO this is why M/A rockstar Karen Smith ( EMD Director) is going to change the future of all EMD shareholders.

1: Dr. Karen Smith was previously Chief Medical Officer and Global Head of Research & Development at "Jazz Pharmaceuticals"
https://hotcopper.com.au/posts/57925859/single


2: "Jazz Pharmaceuticals subsidiary GW Pharmaceuticals" (Epidyolex) is the world’s only plant-derived, CBD-only medicine registered with both the FDA and TGA
https://investor.jazzpharma.com/news-releases/news-release-details/gw-pharmaceuticals-receives-approval-epidyolexr-cannabidiol-mhra
https://investor.jazzpharma.com/news-releases/news-release-details/jazz-pharmaceuticals-completes-acquisition-gw-pharmaceuticals
https://www.newcannabisventures.com/jazz-pharma-reports-pro-form-epidiolex-sales-grew-32-to-156-million-in-q2/



3: In a comparative animal model, EMD-003 showed higher peak blood concentrations and greater bioavailability compared to (Epidyolex ) over 24 hours. In basic terms EMDs better, considerably better and cheaper to produce


4: EMD ( If Successful ) will be in direct competition to the monster Jazz Pharmaceuticals US$8.66bill market cap



5: Or Karen Smith Ex Chief Medical Officer and Global Head of Research & Development at "Jazz Pharmaceuticals", now Director of EMD could simply pick up the phone to her old boss and offer up a deal they simply can not refuse IMO I think that's exactly what's going to or has happened !



6: US$18.2bill M/A J/V under Karen Smiths belt the last few Years !



7: EMD-003 is comprised of ultra-pure CBD and FDA-approved ingredients, simplifying future registration with major regulators like the Therapeutic Goods Administration (TGA) in Australia and the Food and Drug Administration (FDA) in the USA


Thanks to the above whatever is going to happen, I reckon its going to happen fast !